Learn about the emerging companies, finance trends, and strategic drivers impacting the global medtech industry.
SIVA Therapeutics mission is to develop minimally invasive devices for cancer treatment.
BIOMODEX develops 3D printed solutions for patient-specific rehearsal and physician training using realistic models that provide biomechanical, imaging, and fluid dynamics
NeoPredix is utilizing digital health solutions and intelligent algorithms to support maternal, neonatal, and perinatal care. The company's prediction software will support clinical decision makers, allowing them to personalize and optimize patient care based on deep medical data and science.
The Innovo device engages the pelvic floor muscles via 30 minute sessions that have been clinically proven to reduce and eliminate leaks due to stress urinary incontinence.
The company's first solution, KINO, is a digital health platform to support heart failure patients and their physicians that uses AI to provide predictive insights to improve patient management.
Endoluxe is a world-class wireless endoscopic video imaging organization launching its industry design award-winning Endoluxe EVS Orb.
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging.
Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data.
Newronika is developing AlphaDBS, a closed-loop deep brain neuromodulation system for the management of symptoms due to Parkinson's disease.
inHeart's technology generates a 3D map of the patient's heart from medical images to provide physicians with a highly detailed anatomical map, including structural substrate for both ventricles and atria.
SurePulse Medical has developed SurePulse VS, a wireless heart rate monitor specifically designed for newborns.
Green Sun Medical is developing a technology-enabled spinal brace that applies reduction forces dynamically, both allowing the patient to move and generate the constant corrective forces necessary to reverse deformity due to scoliosis.
Reveal Surgical's Sentry system is using advanced optical techniques such as Raman spectroscopy along with sophisticated machine learning algorithms to identify tissues with diffusely infiltrative cancer in vivo, while in surgery.
MIM Solutions is using artificial intelligence and machine learning to address the worldwide fertility disorder occurring in an increasing number of countries. The company is currently developing two solutons that utilize AI to help couples struggling with infertility to conceive.
Vivasure's PerQseal closure device is touted as the first fully bioabsorbable, sutureless and entirely synthetic option to close large-bore arteriotomies that result from percutaneous transcatheter procedures like transcatheter aortic valve replacement (TAVR) and endovascular abdominal aortic aneurysm repair (EVAR).
A conversation with a world renowned cardiac surgeon and legendary innovator. Why does what we do matter? Where can (and should) we go as an industry?
Definition Health has developed an "end-to-end" approach that offers virtual management, pre-operative assessment, and post-operative recovery monitoring for patients undergoing elective surgeries.
BioMEMS has developed a handheld, portable, in-vitro diagnostics platform that can analyze samples in under 3 minutes. The company's point-of-care platform is capable of analyzing samples from blood, mucus, urine and saliva.
CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. Their technology has been applied to products for dental and ophthalmic surgery.
The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.
The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.
Alio's SmartPatch is a discrete patch that continuously monitors and tracks vitals, including O2 saturation, temperature, blood pressure, and more.
They are developing a miniaturized neuromodulation device for therapeutic applications
Bone Health Technologies is developing OsteoBoost, a wearable belt that applies mechanical stimulation to the user in order to reduce bone loss and encourage bone growth in the hips and spine.
The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency.
Adaptix is developing an innovative, miniaturized flat panel X-ray source and associated software to transform existing X-ray systems into Digital Tomosynthesis systems to expand patient access to low-dose 3D imaging.
CereVasc's eShunt System is consists of an endovascularly implantable CSF shunt and associated delivery componentry designed to avoid the need for invasive surgery, general anesthesia, extended hospitalization, and post-procedure pain management.
Neovasc's products include Reducer, for the treatment of refractory angina and Tiara for the transcatheter treatment of mitral regurgitation.
ElectroPhysiology Frontiers is developing a unique, "single-shot" catheter for the ablation of atrial fibrillation. The device is being designed to deliver pulsed-field ablation (PFA) and radiofrequency ablation (RFA) to provide patients with a durable solution and reduce the need for subsequent interventions.
AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF).
